BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kirchweger P, Wundsam HV, Rumpold H. Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies. World J Clin Oncol 2022; 13(6): 473-484 [PMID: 35949436 DOI: 10.5306/wjco.v13.i6.473]
URL: https://www.wjgnet.com/1007-9327/full/v13/i6/473.htm
Number Citing Articles
1
Zsolt Fekete, Andrea Fekete, Gabriel Kacsó. Treatment Classification by Intent in Oncology—The Need for Meaningful Definitions: Curative, Palliative and Potentially Life-ProlongingJournal of Personalized Medicine 2024; 14(9): 932 doi: 10.3390/jpm14090932
2
Patrick Kirchweger, Bernhard Doleschal, Holger Rumpold, Helwig Wundsam, Matthias Biebl. Personalized decision making of neoadjuvant chemotherapy vs. upfront surgery in pancreatic cancer by a simple blood collection?memo - Magazine of European Medical Oncology 2025; 18(1): 49 doi: 10.1007/s12254-024-01013-4
3
Ekaterina S. Kuligina, Grigoriy A. Yanus, Evgeny N. Imyanitov. Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectivesExploration of Targeted Anti-tumor Therapy 2025; 6 doi: 10.37349/etat.2025.1002333
4
Andrea Pretta, Eleonora Lai, Clelia Donisi, Dario Spanu, Pina Ziranu, Valeria Pusceddu, Marco Puzzoni, Elena Massa, Mario Scartozzi. Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?World Journal of Clinical Oncology 2022; 13(12): 980-983 doi: 10.5306/wjco.v13.i12.980
5
Cayce Nawaf, Alexander Shiang, Pradeep S. Chauhan, Aadel A. Chaudhuri, Gautum Agarwal, Zachary L. Smith. Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-invasive bladder cancer guided by modern clinical trialsTranslational Oncology 2023; 37: 101763 doi: 10.1016/j.tranon.2023.101763
6
Rocío Olivera-Salazar, Gabriel Salcedo Cabañas, Luz Vega-Clemente, David Alonso-Martín, Víctor Manuel Castellano Megías, Peter Volward, Damián García-Olmo, Mariano García-Arranz. Pilot Study by Liquid Biopsy in Gastrointestinal Stromal Tumors: Analysis of PDGFRA D842V Mutation and Hypermethylation of SEPT9 Presence by Digital Droplet PCRInternational Journal of Molecular Sciences 2024; 25(12): 6783 doi: 10.3390/ijms25126783
7
Binbin Han, Fuliang Zhang, Zhenyun Chang, Fang Feng. Optimising Deep Neural Networks for Tumour Diagnosis Algorithms Based on Improved MRFO AlgorithmEAI Endorsed Transactions on Pervasive Health and Technology 2024; 10 doi: 10.4108/eetpht.10.5147
8
William Yang, Romario Nguyen, Fatema Safri, Muhammad J. A. Shiddiky, Majid E. Warkiani, Jacob George, Liang Qiao. Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and PrognosisCurrent Oncology Reports 2025; 27(6): 791 doi: 10.1007/s11912-025-01681-3
9
Anu Kumari, Anupriya Kaur, Charanpreet Singh, Anju Goyal, Arihant Jain, Aditya Jandial, Priyanka Srivastava, Sreejesh Sreedharanunni, Amanjit Bal, Alka Rani Khadwal, Pankaj Malhotra, Gaurav Prakash. Prognostic Value of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL): Systematic Review and Meta-AnalysisIndian Journal of Hematology and Blood Transfusion 2025;  doi: 10.1007/s12288-025-02234-1
10
Matthew Krell, Brent Llera, Zachary J. Brown. Circulating Tumor DNA and Management of Colorectal CancerCancers 2023; 16(1): 21 doi: 10.3390/cancers16010021